21CCSS 21st CENTURY CARDIOTHORACIC SURGICAL SOCIETY | Login |
Chris Malaisrie at STS 2020 - Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery https://www.tctmd.com/news/safer-quicker-discharge-protocols-enhanced-recovery-after-surgery February 7, 2020 |
Surgical Training for Transcatheter Aortic Valve Replacement Thursday, October 17, 2019 By David Fullerton, J. James Edelman, Anita Krueger, Tom C. Nguyen, Tsuyoshi Kaneko |
Aortic Stenosis: Watchful Waiting Works Only for So Long | Dad of 10's minimally invasive heart surgery cuts recovery time |
|
Max Emmert, MD - Winner of the New Technology Award at 2019 EACTS - Lisbon |
Seenu Reddy, Dan Engelman and Louis Perrault speaking on behalf of ERAS Cardiac at 2019 EACTS - Lisbon |
Seenu Reddy, MD - Interview with Local Television Station New Advances Before and After Heart Surgery - 9-17-19 | Daniel T. Engelman, MD;Walid Ben Ali, MD; Judson B. Williams, MD, MHS; Louis P. Perrault, MD, PhD; V. Seenu Reddy, MD; Rakesh C. Arora, MD, PhD; Eric E. Roselli, MD; Ali Khoynezhad, MD, PhD; Marc Gerdisch, MD; Jerrold H. Levy, MD; Kevin Lobdell, MD; Nick Fletcher, MD, MBBS; Matthias Kirsch, MD; Gregg Nelson, MD; Richard M. Engelman, MD; Alexander J. Gregory, MD; Edward M. Boyle, MD |
Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac ... | Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-1705. |
21CCSS Member Billy Cohn: Renowned heart surgeon and inventor to lead J&J innovation center Dec 3, 2016 - World-renowned heart surgeon and inventor to lead innovation centerDevice ... invention, Johnson & Johnson Innovation will open a center next year .. | Baltimore Sun Dec 6, 2017 Baltimore-based Harpoon Medical acquired for $100 million The device's inventor, Dr. James. S. Gammie, is the chief of cardiac surgery at the University of Maryland Medical Center and a professor at the ... |
Early AVR bests 'watchful waiting' in asymptomatic patients | Past SAVR Outcomes Matter More Than Volume in Determining Future Performance MedPage Today |
Dramatic Surge in Opioid Use Among Cardiac Surgery Patients | Is There a Volume-Outcome Relationship With Newer TAVR Valves ... |
Survival Better With Early AVR for Severe Asymptomatic Aortic ... | TAVR-Heavy Centers Cutting Back on SAVR implies that higher risk patients are most likely appropriately undergoing TAVR rather than SAVR," said one group led by Vinod Thourani, MD, of MedStar Heart and Vascular Institute and Georgetown ... |
21CCSS Member Billy Cohn on TEDMed TEDMed.com - If you have an artificial heart, does that make you heartless? |
Knowledge sharing, device improvements may shrink TAVR learning ... | TCTMD Jul 25, 2018 STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical ... “It gives us a really good snapshot of what's going on with mitral valve surgery,” the study's lead author, James S. Gammie, MD (University of ... |
Edwards Lifesciences buys Harpoon Medical for up to $250M ... Cardiovascular Business Dec 7, 2017 we believe can benefit from Harpoon's therapy during a minimally invasive, beating-heart procedure," said device inventor James S. Gammie, professor and chief of cardiac ... |
Aortic Stenosis: Watchful Waiting Works Only for So Long | Science Daily Nov 1, 2017 Innovative heart device is safe and effective, study finds: Device may ... device was found to be remarkably safe and effective," says the study's principal investigator and an inventor of the device, James S. Gammie ... |
American College of Cardiology12d NCDR-Derived Risk Model to Predict Inhospital Stroke After TAVR The study was published in The Annals of Thoracic Surgery. Vinod H. Thourani, MD, FACC, et al., identified 97,600 patients who underwent TAVR procedures at 521 sites from July 2014 to June 2017. Past SAVR Outcomes Matter More Than Volume in Determining Future Performance “In the era of the changing role of AVR and the management of aortic valve disease, there should be continued vigilance in improving valve surgery outcomes,” said lead researcher Vinod Thourani, MD ... TCTMD10mon BIOENGINEER5mon In study, TAVR is superior to surgery for low-risk patients with aortic valve stenosis The authors are Michael Mack (Baylor, Scott and White, Plano, TX), Vinod Thourani (Georgetown University, Washington, DC), Martin Leon (Columbia University Irving Medical Center and ...
TCTMD8mon
Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US Tom Cahill In an accompanying editorial, Vinod Thourani, MD (MedStar Heart and Vascular Institute, Washington, DC), and colleagues argue for additional data to home in on the exact relationship ...
TCTMD10mon
PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes Vinod Thourani, MD (MedStar Heart and Vascular Institute, Washington, DC), who was not involved in the studies, congratulated investigators for completing 10-year follow-up in the trials, noting that .. Long-term Off-Pump CABG Results Deflate in Large, Real-world Study In an accompanying editorial, Faisal G. Bakaeen, MD (Cleveland Clinic Heart and Vascular Institute, OH) and Vinod H. Thourani, MD (MedStar Heart and Vascular Institute, Washington, DC), say the ... TCTMD11mon TCT: MitraClip Saves Lives in Functional Mitral Regurgitation "For such patients, the MitraClip should be the standard of care." "This in a lot of way in my mind trumps the neutrality of results that MITRAL-FR had," commented Vinod Thourani, MD, of MedStar Heart ... MedPage Today10mon UMB News Jul 24, 2018 The Risks of Delaying Mitral Valve Surgery The study, led by James S. Gammie, MD, professor of surgery at the University of Maryland School of Medicine (UMSOM) and chief of cardiac .. Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death Kosinski PhD, of the Duke Clinical Research Institute, David J. Malenka MD, FACC, of Dartmouth-Hitchock, and Vinod H. Thourani MD, FACC, of MedStar Heart and Vascular Institute and Georgetown ... EurekAlert!10mon | Should Surgical Risk Be 'Off the Table' When Deciding on Eligibility for ... In study, TAVR is superior to surgery for low-risk patients with aortic ... |